American Society of Clinical Oncology

Type: Organization
Name: American Society of Clinical Oncology
First reported 5 hours ago - Updated 5 hours ago - 1 reports

Will doctors weighing costs vs. treatment be bad medicine?

Saying they can no longer ignore the rising price of health care, some of the most influential groups in the nation are recommending that doctors weigh the costs, not just the effectiveness of treatments, as they make decisions about patients.The shift, ... [Published Idaho Statesman - 5 hours ago]
First reported 18 hours ago - Updated 7 hours ago - 1 reports

ASCO at work on a scoring system to weigh cost vs. potential benefits of pricey cancer treatments

Cancer doctors and patients need a better way to weigh the potential benefits of new targeted cancer treatments against their costs, especially those that carry a price tag north of tens of thousands of dollars per month .That’s why the American Society ... [Published MedCity News - 18 hours ago]
First reported Apr 16 2014 - Updated 19 hours ago - 4 reports

ASCO Physicians Consider Cost-Effectiveness of Expensive Oncology Drugs

The American Society of Clinical Oncology is weighing efficacy, side effects and price using an algorithm to determine the relative value of drugs, focusing first on therapies for advanced cases of lung and prostate cancer and for multiple myeloma, said ... [Published American Journal of Managed Care - 19 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Skin Docs Prescribe Costlier Drugs After Free Samples

In other news, panels recommend a costly hepatitis C drug for the sickest patients, and cancer doctors will compare the value of costly cancer drugs.NPR : Free Drug Samples Prompt Skin Doctors To Prescribe Costlier MedsEvery "free" sample comes with a ... [Published Kaiser Health News - 21 hours ago]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

ER Immunohistochemistry of Breast Core Biopsies

Victoria Sujoy, MD, Mehrdad Nadji, MD, Azorides R. Morales, MDDisclosuresAm J Clin Pathol. 2014;141(4):522-526.Abstract and Introduction AbstractObjectives: Recent studies have questioned the supporting evidence for the American Society of Clinical ... [Published General Medicine eJournal - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Prevention: Stop Cancer Before It Starts

Hi. This is Dr. Kathy Miller from Indiana University in Indianapolis, Indiana. Medscape editors recently asked the regular oncology bloggers to consider a very simple question: If we had the power to do it, which single "calcified" feature of the oncology ... [Published American Journal of Public Health - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

ASCO, ESMO, EORTC, ESO, and UICC Continue Endorsing the WIN Symposium Series in 2014

VILLEJUIF, France--(BUSINESS WIRE)-- Five major cancer organizations which have endorsed previous events in the WIN Symposium Series, are also endorsing the WIN 2014 Symposium, to be held in Paris, June 23 - 24. The high scientific level and expected ... [Published CNBC - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

ASCO Report Captures Pressures on Oncology Specialists

Table 1. Pressures Cited by Practices by YearThe State of Cancer Care in America: 2014, American Society of Clinical Oncology.Table 2. Private Community Practice Likelihood to Undergo Practice ChangeThe State of Cancer Care in America: 2014, American ... [Published OncLive - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

New ASCO Guidelines for the Care of Cancer Survivors

The American Society of Clinical Oncology (ASCO) today issued three evidence-based clinical practice guidelines on the prevention and management of symptoms that affect many cancer survivors—neuropathy, fatigue and depression, and anxiety. The guidelines ... [Published American Journal of Managed Care - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Tips in a Minute: What is Cancer Related Distress?

ASCO: Cancer Patients Want to Talk About Costs With DocsMay 31, 2013 - Although financial distress is common, even in insured patients, discussion of costs of cancer care with doctors rarely happens, according to research to be presented at the annual ... [Published OncoLink - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 2 reports

First ASCO survivor care guidelines tackle fatigue, anxiety/depression, neuropathy

The American Society of Clinical Oncology has issued three new practice guidelines related to fatigue; anxiety and depression; and chemotherapy-induced peripheral neuropathy in patients with... ... [Published Ob.Gyn. News - Apr 15 2014]
First reported Apr 12 2014 - Updated Apr 12 2014 - 1 reports

Pa. faces growing cancer-rate challenge

Pennsylvania has relatively high cancer rates, many rural counties with no cancer specialists, rising cancer care costs, and shrinking reimbursements."We face a perfect storm of challenges," said Marilyn Heine, a hematologist-oncologist with a group practice ... [Published Philly.com - Apr 12 2014]

Quotes

"Protecting patients from financial ruin is fundamental to the precept of 'do no harm,' " the societies wrote in their paper outlining new rules
Lowell Schnipper, the task force chairman, said the value ratings may cause drugmakers to reassess their pricing policies. "My guess is that something like this can have a modulating effect" Dr. Schnipper, who is also chief of hematology and oncology at Beth Israel Deaconess Medical Center in Boston, said in an interview...
...our clinical development plan, which currently includes 10 Phase III studies," said Bob Duggan , CEO and Chairman of the Board of Pharmacyclics . "Our company's mission is to serve as an ally to patients. In the RESONATE study, single agent IMBRUVICA provided a significant benefit for patients with CLL. We look forward to working with the FDA as they review the data from this Phase III study."
...in patients with chronic lymphocytic leukemia who have received prior therapy," said Peter F Lebowitz , M D , Ph D , Global Oncology Head, Janssen. "We and our collaboration partner Pharmacyclics are focused on ways to bring this medicine to patients as quickly as possible and this is one more important milestone in the development of this product."

More Content

All (288) | News (265) | Reports (0) | Blogs (18) | Audio/Video (0) | Fact Sheets (0) | Press Releases (5)
sort by: Date | Relevance
Will doctors weighing costs vs. treatment be ba... [Published Idaho Statesman - 5 hours ago]
Medical Groups To Weigh Costs of Drugs in Care [Published Columbus - 9 hours ago]
Sweetened Beverages, Coffee, and Tea and Depres... [Published PLoS medicine - 13 hours ago]
DeNovo Sciences Releases Its First Commercial I... [Published BioSpace - 14 hours ago]
ASCO at work on a scoring system to weigh cost ... [Published MedCity News - 18 hours ago]
ASCO Physicians Consider Cost-Effectiveness of ... [Published American Journal of Managed Care - 19 hours ago]
Skin Docs Prescribe Costlier Drugs After Free S... [Published Kaiser Health News - 21 hours ago]
Doctors to rate cost effects of expensive cance... [Published Pittsburgh Post-Gazette - 21 hours ago]
Clinical trial to test multiple drugs [Published Columbus Dispatch - 23 hours ago]
HER2-Positive Breast Cancer: The Story Goes On [Published Cancernetwork.com - Apr 17 2014]
ER Immunohistochemistry of Breast Core Biopsies [Published General Medicine eJournal - Apr 17 2014]
Pharmacyclics Files Supplemental New Drug Appli... [Published HispanicBusiness.com - Apr 17 2014]
PHARMACYCLICS : Supplemental New Drug Applicati... [Published 4 Traders - Apr 17 2014]
Cancer Doctors Plan to Compare Value of Expensi... [Published FirstWord Pharma - Apr 16 2014]
Cancer Doctors Plan to Rate Expensive Drugs’ Co... [Published Washington Post - Apr 16 2014]
Prevention: Stop Cancer Before It Starts [Published American Journal of Public Health - Apr 16 2014]
GI Research Improving Quality of Life in Rectal... [Published Oncology Times - Apr 16 2014]
Current Thinking on Breast Atypia Expanded by N... [Published Oncology Times - Apr 16 2014]
ASCO Survey: Oncologists Less Happy with Work-L... [Published Oncology Times - Apr 16 2014]
ASCO, ESMO, EORTC, ESO, and UICC Continue Endor... [Published CNBC - Apr 16 2014]
UCLA’s Christofk Lab’s may have clues to fighti... [Published U-Wire.com - Apr 16 2014]
Jim Allison confronts cancer, critics with immu... [Published San Francisco Chronicle - Apr 16 2014]
ASCO Report Captures Pressures on Oncology Spec... [Published OncLive - Apr 15 2014]
New ASCO Guidelines for the Care of Cancer Surv... [Published American Journal of Managed Care - Apr 15 2014]
Tips in a Minute: What is Cancer Related Distress? [Published OncoLink - Apr 15 2014]
First ASCO survivor care guidelines tackle fati... [Published Ob.Gyn. News - Apr 15 2014]
First ASCO survivor care guidelines tackle fati... [Published Oncology Report - Apr 15 2014]
ASCO Releases First Three Guidelines on Cancer ... [Published American Society of Clinical Oncology - Apr 14 2014]
Nelson Regional Breast Cancer Trust focus on su... [Published Voxy.co.nz - Apr 14 2014]
Dr. Steele to give keynote at Healthcare Busine... [Published TickerTech.com - Apr 14 2014]
1 2 3 4 5 6 7 8 9 10
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ASCO: SNL the New Standard for Early Breast Ca [Published MedPageToday.com - medical news plus CME for ph ... - Apr 03 2014]
(MedPage Today) -- Breast cancer patients with negative sentinel node biopsies can skip axillary lymph node dissection, according to an updated clinical guideline from the American Society of Clinical Oncology. ...
Provectus Biopharmaceuticals’ PV-10 Data to Fea... [Published Business Wire Health News - Apr 02 2014]
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals' PV-10 Data to Feature in Poster Presentation by Moffitt Cancer Center at ASCO ...
Provectus Biopharmaceuticals’ PV-10 Data to Be ... [Published EON Science - Apr 01 2014]
KNOXVILLE, Tenn.--(EON: Enhanced Online News)--Provectus Biopharmaceuticals' PV-10 To Be Presented At the American Society of Clinical Oncology ...
Provectus Biopharmaceuticals’ PV-10 Data to Be ... [Published Business Wire Science: Science News - Apr 01 2014]
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals' PV-10 To Be Presented At the American Society of Clinical Oncology ...
Provectus Biopharmaceuticals’ PV-10 Data to Be ... [Published Business Wire Health News - Apr 01 2014]
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals' PV-10 To Be Presented At the American Society of Clinical Oncology ...
1 2 3 4

Press Releases

sort by: Date | Relevance
Immunicum’s abstract with data from a kidney ca... [Published GlobeNewswire: Acquisitions News - Mar 27 2014]
Dune Medical, Maker of the MarginProbe Welcomes... [Published GlobeNewswire: Advertising News - Feb 21 2014]
Karyopharm Therapeutics Announces Data Presenta... [Published GlobeNewswire: Acquisitions News - Jan 14 2014]
Merrimack to Present Preclinical Data at the Am... [Published GlobeNewswire: Acquisitions News - Jan 13 2014]
Research study aims to understand inherited lun... [Published PR Newswire - Oct 30 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.